UPDATE 1-Celgene's adjusted profit beats estimates on demand for Revlimid

Jan 26 (Reuters) - Celgene Corp on Thursday reported a better-than-expected adjusted profit for the fourth quarter, helped by demand for its flagship multiple myeloma drug, Revlimid. [Source]

Publication Date: Thursday, 26 January 2017 at 15:00:43

Origin: reuters.com

Category: hotStocksNews

Topics: Revlimid, demand, profit, adjusted, myeloma drug, multiple, flagship, helped, fourth quarter, better-than-expected, Thursday reported, Celgene, (Reuters), estimates, beats, 1-Celgene's, UPDATE

Source: http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/7xn85aoiH-k/celgene-results-idUSL4N1FG3QF

UPDATE 1-Ferrari races to new high after earnings top forecast

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 16:48:11

UPDATE 2-Ralph Lauren CEO to leave after differences with founder

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 16:24:14

UPDATE 1-Sterling, gilt yields skid as BoE seems in no rush to raise rates

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 16:03:29

UPDATE 2-Fingerprint Cards suffers fresh setback with weak outlook

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 14:30:03

UPDATE 3-Daimler pursues new records in tougher environment

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 14:27:59

Analyzed News